Monday, August 31, 2026
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
News articleYahoo Finance· February 2, 2026

Interactive Brokers Group Reports Brokerage Metrics and Other Financial Information for January 2026, includes Reg.-NMS Execution Statistics

View original at finance.yahoo.com
Interactive Brokers Group Reports Brokerage Metrics and Other Financial Information for January 2026, includes Reg.-NMS Execution Statistics GREENWICH, Conn., February 02, 2026--(BUSINESS WIRE)--Interactive Brokers Group, Inc…
Opening lines of the source · Yahoo Finance · short snapshot — read the full document at the original

What we drew from this source

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • Average U.S. Reg-NMS stock trade was $21,785 in January 2026

    80% confidence
  • IBKR PRO clients' total cost of executing and clearing U.S. Reg.-NMS stocks was about 1.9 basis points in January 2026

    80% confidence
  • Interactive Brokers has consistently earned recognition as a top broker, garnering multiple awards and accolades from respected industry sources

    80% confidence
  • Exchange, clearing and regulatory fees are estimated to be 60% of futures commissions

    80% confidence
  • Rolling twelve months' average all-in cost of IBKR PRO client U.S. Reg.-NMS stock trade was 2.6 basis points

    80% confidence

Cited in these Via News reports

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Hawkish Fed Signals at Jackson Hole Pressure Rate-Sensitive Assets
Kevin Warsh's hawkish inflation remarks at Jackson Hole, alongside a steady drumbeat of Federal Reserve testimony from Powell, Barr, Bowman and other officials on supervision, regulation and monetary policy, signal continued vigilance against inflation rather than an imminent easing cycle. Rate-sensitive and precious-metals-linked names such as SSR Mining sold off the same day, consistent with markets repricing for a firmer-for-longer policy stance.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
We flag conflicts openly ›
Recently verified
Checked against the original source
4,979
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,979 facts checked against source5,261 source documents archived
Query this data → isubstrate.com